Two patients suffering from NSCLC with a novel rearrangement mutation in RET (exon2-11del) and their response to pralsetinib as salvage treatment. - Huang, Zhen-Jie; Zhao, Sha; Lin, Bi-Lin; Ma, Xin-Yi; Huang, Long (Lung Cancer (01695002), 2025)